NAFDAC Guidelines for Inspection of Facilities for Manufacture of Veterinary Drugs in Nigeria
Guideline · Health
Guidelines provide criteria for inspecting facilities that manufacture veterinary drugs. They target producers and NAFDAC compliance teams. This ensures the drugs are safe, quality-assured, and effective for animals.
NAFDAC Guidelines for Inspection of Facilities for Manufacture of Veterinary Drugs in Nigeria
What Is This Policy?
Guidelines for inspecting facilities that manufacture veterinary pharmaceutical products in Nigeria, covering GMP standards, quality control, and safety requirements specific to animal health products.
Who Does It Target?
Regulated entities as applicable NAFDAC inspection and compliance teams Industry stakeholders
What Does It Aim to Achieve?
Ensure veterinary drugs are manufactured under conditions that guarantee safety, quality, and efficacy for animal use.
Key Features
GMP Standards: Good Manufacturing Practice requirements adapted for veterinary pharmaceuticals Cross-Contamination: Separation of production lines for different product types Quality Control: Testing of raw materials, in-process samples, and finished products Residue Data: Withdrawal period information for products used in food-producing animals
Current Status
Rollout Stage: Active Coverage: All applicable regulated entities Lead Agency: NAFDAC
How to Access
Regulated entities must comply with these guidelines. Establish GMP-compliant veterinary drug facility Apply for product registration Undergo NAFDAC facility inspection
Official Resources
Website: nafdac.gov.ng Contact: NAFDAC, Abuja
Legal Framework
Issued under the National Agency for Food and Drug Administration and Control Act 1993 (as amended). Operates alongside the Veterinary Surgeons Act, the Veterinary Council of Nigeria Act, the Food and Drugs Act Cap F32 LFN 2004, WHO/OIE Codex Alimentarius standards on veterinary drug residues, and the Standards Organisation of Nigeria Act 2015.